Actemra
NDC 50242-138, tocilizumab, injection, solution, from Genentech, Inc..
- Product NDC
- 50242-138
- Status
- Listed
- Labeler
- Genentech, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA125472
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50242-138 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TOCILIZUMAB162 mg/.9mL
Pharmacologic classes
Interleukin 6 Receptor Antagonists [MoA]; Interleukin-6 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50242-138-01 | 50242013801 | 1 SYRINGE, GLASS in 1 BOX (50242-138-01) / .9 mL in 1 SYRINGE, GLASS |
| 50242-138-86 | 50242013886 | 1 SYRINGE, GLASS in 1 BOX (50242-138-86) / .9 mL in 1 SYRINGE, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/2e5365ff-cb2a-4b16-b2c7-e35c6bf2de13
Use it
Look up 50242-138 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50242-138 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50242-138. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.